Serolojik Tanı Yöntemleri

Yazarlar

Zeynep Sarıbaş

Referanslar

Wang Q, Nag D, Baldwin SL, Coler RN, McNamara Ryan P. Antibodies as key mediators of protection against Mycobacterium tuberculosis. Front. Immunol. 2024; 15:1430955. doi: 10.3389/fimmu.2024.1430955.

McIntyre S, Warner J, Rush C, Vanderven HA. Antibodies as clinical tools for tuberculosis. Front. Immunol.2023; 14:1278947. doi: 10.3389/fimmu.2023.1278947.

Bekmurzayeva A, Sypabekova M, Kanayeva,D. Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis. Tuberculosis 2013; 93(4) p:381-388.

Melkie ST, Arias L, Farroni C, Makek MJ, Goletti D, Vilaplana C. The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group. Eur Respir Rev 2022; 31:210218. doi.org/10.1183/16000617.0218-2021.

Yue C, Geng X, Sun X, Liu J, Zhang D, Li L. Emerging blood-based diagnostic strategies for tuberculosis. Clin Chem Lab Med 2026; doi: 10.1515/cclm-2026-0123.

WHO/HTM/TB/2014.18. High-priority target product profiles for new tuberculosis diagnostics report of a consensus meeting.2014

Ou X, Liu G, Peng B, Li Y, Yan H, Chu N, Zhao B, Zhao Y, Du J. Safety,tolerability, and concordance with interferon-γ release assays of recombinant ESAT6–MPT64 skin test: a phase 1 randomized clinical trial. Front. Immunol.2026; 17:1780294.doi:10.3389/fimmu.2026.1780294

Yin X, Zheng L, Lin L, Hu Y, Zheng F, Hu Y, Wang Q. Commercial MPT64-based tests for rapid identification of Mycobacterium tuberculosis complex: A meta-analysis. Journal of Infection, 2013; 67: 369-377.

Chew KL, Lin RTP, T JWP. MPT64 gene mutations leading to non-reactivity on a rapid immunochromatographic assay. J Infect Dev Ctries 2017; 11(4): 371-373.doi:10.3855/jidc.8768

Sanoussi CN, Jong BC, Odoun M, Arekpa K, Ligali MA, Bodi O, Harris S, Ofori-Anyinam B, Yeboah-Manu D, Otchere ID, Asante-Poku A, Anagonou S, Gagneux S, Coscolla M, Rigouts L, Affolabi D. Low sensitivity of the MPT64 identification test to detect lineage 5 of the Mycobacterium tuberculosis complex. J Med Microbiol 2018; 67:1718–1727 DOI 10.1099/jmm.0.000846.

Song Z, He W, Pei,S, Zhao B, Cao,X, Wang Y, He P, Liu D, Ma A, Ou X, Xia H, Wang S, Liu C, Zhao Y. Association of lineage 4.2.2 of Mycobacterium tuberculosis with the 63-bp deletion variant of the mpt64 gene. Microbiol Spectr. 2023; 12;11(6): e0184223. doi: 10.1128/spectrum.01842-23.

Babaki MKZ, Soleimanpour S, Rezaee SA. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications indiagnosis, and vaccine design. Microb Pathog. 2017; 112:20-29. doi: 10.1016/j.micpath.2017.08.040.

Kashyap RS, Rajan AN, Ramteke SS, Agrawal VS, Kelkar SS, Purohit HJ, Taori GM, Daginawala HF. Diagnosis of tuberculosis in an Indian population by an indirect ELISA protocol based on detection of Antigen 85 complex: a prospective cohort study. BMC Infect Dis. 2007; 10:7:74doi: 10.1186/1471-2334-7-74.

Kumar G, Dagur P, Singh M, Yadav VS, Dayal R. Singh HB, Katoch VM Sengupta U, Joshi B. Diagnostic potential of Ag85C in comparison to various secretory antigens for childhood tuberculosis. Scand J Immunol. 2008; 68(2):177-83.

Nagdev KJ, Kashyap RS, Deshpande PS, Purohit HJ, Taori GM, Daginawala HF. Comparative evaluation of a PCR assay with an in-house ELISA method for diagnosis of tuberculous meningitis. Med Sci Monit 2010; 16(6): CR289-295.

Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol. 2004 ;53(2):391-403 doi: 10.1111/j.1365-2958.2004.04183.

Flores J, Cancino JC, Chavez-Galan L. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Front Microbiol. 2021:15:12:638047. doi: 10.3389/fmicb.2021.638047.

Sarkar P, Biswas D, Sindhwani G, Rawat J, Kotwal A, Kakati B. Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It? Postgrad Med J. 2014; 90(1061):155-63. doi: 10.1136/postgradmedj-2013-132053.

Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012; 26:12:103. doi: 10.1186/1471-2334-12-103.

Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2012; 12(3):201–209. doi: 10.1016/S1473-3099(11)70251-1.

Zhang Z, Dong L, Li X, Deng T, Wang Q. The PE/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control. Front Immunol. 2025 17:16:1606311. doi: 10.3389/fimmu.2025.1606311.

D’Souza C, Kishore U, Tsolaki AG. The PE-PPE Family of Mycobacterium tuberculosis: Proteins in Disguise. Immunobiology 2023; 228(2):152321. doi: 10.1016/j.imbio.2022.152321.

Abraham PR, Devalraju KP, Jha V, Valluri VL, Mukhopadhyay S. PPE17 (Rv1168c) protein of Mycobacteriumn tuberculosis detects individuals with latent TB infection. PLoS One 2018; 26;13(11): e0207787. doi: 10.1371/journal.pone.0207787. eCollection 2018.

Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L. Khan HI, Cattamanchi A. Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.. PLoS One 2017 Aug 2;12(8):e0180122. doi: 10.1371/journal.pone.0180122. eCollection 2017.

Baumann R, Kaempfer S, Chegou NN, Oehlmann W, Loxton AG, Kaufmann SHE, van Helden PD, Black GF, Singh M, Walzl G. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets. J Infect. 2014; 69(6):581-9. doi: 10.1016/j.jinf.2014.05.014.

Awoniyi DO, Baumann R, Chegou NN, Kriel B, Jacobs R, Kidd M, Loxton AG, Kaempfer S, Singh M, Walzl G. Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB. Oncotarget 2017; Jun 6;8(23):37525-37537. doi: 10.18632/oncotarget.16401.

Yayınlanan

17 Kasım 2026

Lisans

Lisans